Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Pathos: The company raised $283 million of venture funding from undisclosed investors on May 1, 2025. The company is a developer of a drug discovery platform intended to reduce the...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions SHINE Technologies: The company received $122.5 million of development capital from undisclosed investors on April 21, 2025. The company is a developer of medical isotopes designed...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Glycomine: The company raised $115 million of Series C venture funding in a deal led by Advent Life Sciences and CTI Life Sciences Fund on April 16, 2025. Chiesi Ventures, Novo...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Merida Biosciences: The company raised $121 million of Series A venture funding in a deal led by Bain Capital Life Sciences, Third Rock Ventures and BVF Partners on April 8, 2025. GV...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Isomorphic Labs: The company raised GBP 449 million of venture funding in a deal led by Thrive Capital on March 31, 2025, putting the company’s pre-money valuation at GBP 942...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Supira Medical: The company raised $120 million of Series E venture funding in a deal led by Novo Holdings and Qatar Investment Authority on March 26, 2025, putting the...
